<DOC>
	<DOCNO>NCT02207465</DOCNO>
	<brief_summary>The investigator hypothesize intensification local therapy lead improvement local control survival patient unresectable borderline resectable pancreatic cancer . The investigator propose combine nab-paclitaxel concurrently dose-escalated radiation therapy . In first part phase I study ( sub-trial 1 ) , nab-paclitaxel dose escalate radiation dose hold constant standardly accept level . The use novel chemoradiotherapy regimen take advantage nab-paclitaxels specific anti-tumor anti-stromal property , may enhance efficacy radiation therapy , thereby improve local control . After MTD nab-paclitaxel determine , second part study ( sub-trial 2 ) , investigator administer nab-paclitaxel determined MTD concurrently escalate dos radiation . The investigator utilize combination proton IMRT safely deliver high dos radiation maximally spar surround normal tissue . Patients also preferentially 2-3 fiducial marker place around tumor daily localization treat breath hold order prevent tumor movement normal respiration . Such technique help minimize target volume thereby avoid critical normal structure . The investigator use gemcitabine nab-paclitaxel chemoradiotherapy give promising result metastatic pancreatic cancer patient . Correlative tissue serum biomarkers important , optional , part study .</brief_summary>
	<brief_title>A Phase I Dual Dose Escalation Study Radiation Nab-Paclitaxel Patients With Unresectable Borderline Resectable Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Pathologically confirm adenocarcinoma pancreas . Unresectable disease borderline resectable disease assess multidisciplinary panel pancreas surgeon , medical radiation oncologist , radiologist . Criteria define unresectable borderline resectable patient base NCCN Guidelines ( v 1.2014 ) : Unresectable Greater 180 degree SMA encasement Any celiac abutment Unreconstructible SMV/portal occlusion Aortic invasion encasement Nodal metastases beyond field resection Borderline resectable Venous involvement SMV/portal vein demonstrate tumor abutment impingement narrow lumen Encasement SMV/portal vein without encasement nearby artery Shortsegment venous occlusion result either tumor thrombus encasement suitable proximal distal vessel reconstruction/grafting . Gastroduodenal artery encasement hepatic artery either short segment encasement direct abutment hepatic artery , without extension celiac axis Tumor abutment SMA exceed great 180 degree circumferential vessel wall Age &gt; 18 year . ECOG performance status &lt; 1 . Adequate organ function define follow : absolute neutrophil count ≥ 1500/mm3 , platelet ≥ 100,000/mm3 , serum creatinine ≤ 2 mg/dl , total bilirubin ≤ 3 , ( relief biliary obstruction present ( PTC tube endobiliary stent ) AST &lt; 5 time upper limit normal . Patients reproductive potential must agree use effective contraceptive method participation trial 6 month trial . Patients must able provide write informed consent . Distant metastatic disease . Prior history abdominal radiation therapy . Prior systemic therapy pancreatic cancer . Prior simultaneous malignancy within past 2 year ( cutaneous squamous basal cell carcinoma , melanoma situ , thyroid carcinoma , lowrisk prostate cancer ) . Insitu carcinoma allow . Serious uncontrolled concomitant systemic disorder psychiatric condition would interfere safe delivery protocol therapy . Treatment investigational anticancer agent within 4 week prior enrollment study . Pregnant woman , woman plan become pregnant woman nurse . Patients unable perform breath hold scan planning purpose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>